ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628572 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628572; 2) Community: the network communities that were significantly associated with the response to NSC 628572; 3) Molecule: the relationships between components within communities and NSC 628572; 4) MDR: the compounds that were significantly associated with the NSC 628572.

NSC Compound Enrichment Correlation
NSC 736914 Null 0.0467178916101845 0.39307173
NSC 740276 5,6-Dihydro-6-[3-(hydroxyethyl)amino-1-propyl]-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloide 0.0467178916101845 0.23987656
NSC 747452 3,19-(4-Acetamido)benzylidineandrographolide 0.0467178916101845 0.2039171
NSC 96996 B 169 0.0467178916101845 0.51990259
NSC 745098 21-[2-(N,N-dimethylamino)ethyl]-oxy-.7.alpha.-methyl-19-norpregna-1,3,5(10),17(20)-tetraen-3-ol citrate salt 0.0483128986658386 0.12799453
NSC 621888 Cyclopentanone, 2-[(dimethylamino)methyl]-, hydrochloride (9CI) 0.0483128986658395 0.70329504
NSC 668261 Null 0.0483128986658396 0.64293512
NSC 606497 Camptothecin Derivative 0.0490935610249065 0.15395837
NSC 629595 Null 0.0490935610249068 0.60800338
NSC 630606 1-Piperidinecarboxylic acid, 3,5-bis(phenylmethylene)- 4-oxo-, 4-methylphenyl ester 0.0490935610249068 0.37761639
Total:87  Current:84    [First] [Prev] [Next] [Last]